Moch, H. et al., “Identification of Potential Prognostic Parameters for Renal Cell Carcinoma by Tissue Microarray Analysis and cDNA Microarray Screening”, Verhandlungen der Deutschen Gesellschaft fur Pathologie, vol. 83, 1999, pp. 225-232. |
Penault-Llorca, F. et al., “Optimization of Immunohistochemical Detection of ERBB2 in Human Breast Cancer: Impact of Fixation”, Journal of Pathology, vol. 173, No. 1, May 1994, pp. 65-75. |
Richter, J. et al., “High-Throughput Tissue Microarray Analysis of Cyclin E Gene Amplification and Overexpression in Urinary Bladder Cancer”, American Journal of Pathology, vol. 157, No. 3, Sep. 2000, pp. 787-794. |
Bowen, C. et al., “Loss of NKX3.1 Expression in Human Prostate Cancer Correlates with Tumor Progression”, Cancer Research, vol. 60, No. 21, Nov. 1, 2000, pp. 6111-6115. |
Schrami, P. et al., “Tissue Microarrays for Gene Amplification Surveys in many Different Tumor Types”, Clinical Cancer Research, vol. 5, No. 8, Aug. 1999, pp. 1966-1975. |
Slamon, D.J. et al., “Studies of the HER-2/neu Proto-oncogene in Human Breast and Ovarian Cancer”, Science, vol. 244, May 12, 1999, pp. 707-712. |
Specht, K. et al., “Quantitative Gene Expression Analysis in Microdissected Archival Formalin-Fixed and Paraffin-Embedded Tumor Tissue”, American Journal of Pathology, vol. 158, No. 2, Feb. 2001, pp. 419-429. |
Traweek, S.T. et al., “The Human Hematopoietic Progenitor Cell Antigen (CD34) in Vascular Neoplasia”, Anatomic Pathology, vol. 96, No. 1, 1991, pp. 25-31. |
Werner, M. et al., “Effect of Formalin Tissue Fixation and Processing on Immunohistochemistry”, The American Journal of Surgical Pathology, vol. 24, No. 7, Jul. 2000, pp. 1016-1019. |
Barlund, M. et al., “Multiple Genes at 17q23 Undergo Amplification and Overexpression in Breast Cancer”, Cancer Research, vol. 60, No. 19, Oct. 1, 2000, pp. 5340-5344. |
Battifora, H. et al, “The Influence of Protease Digestion and Duration of Fixation on the Immunostaining of Keratins. A Comparison of Formalin and Ethanol Fixation”, The Journal of Histochemistry and Cytochemistry, vol. 34, No. 8, Aug. 1986, pp. 1095-1100. |
Bubendorf, L. et al., “Survey of Gene Amplifications during Prostate Cancer Progression by High-Throughput Fluorescence in Situ Hybridization on Tissue Microarrays”, vol. 59, No. 4, Feb. 15, 1999, pp. 803-806. |
Bubendorf, L. et al., “Hormone Therapy Failure in Human Prostate Cancer: Analysis by Complementary DNA and Tissue Microarrays”, Journal of the National Cancer Institute, vol. 91, No. 20, Oct. 20, 1999, pp. 1758-1764. |
Barlund, M. et al, “Detecting Activation of Ribosomal Protein S6 Kinase by Complementary DNA and Tissue Microarray Analysis”, Journal of the National Cancer Institute, vol. 92, No. 15, Aug. 2, 2000, pp. 1252-1259. |
Goldsworthy, S.M. et al., “Effects of Fixation on RNA Extraction and Amplification from Laser Capture Microdissected Tissue”, Molecular Carcinogenesis, vol. 25, No. 1, May 1999, pp. 86-91. |
Kononen, J. et al., “Tissue microarrays for high-throughput molecular profiling of tumor specimens”, Nature Medicine, vol. 4, No. 7, Jul. 1998, pp. 844-847. |
Masuda, N. et al., “Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples”, Nucleic Acids Research, vol. 27, No. 22, Nov. 15, 1999, pp. 4436-4443. |
Moch, H. et al., “High-Throughput Tissue Microarray Analysis to Evaluate Genes Uncovered by cDNA Microarray Screening in Renal Cell Carcinoma”, American Journal of Pathology, vol. 154, No. 4, Apr. 1999, pp. 981-986. |